
Core Viewpoint - Zynex, Inc. continues to face a temporary payment suspension from its largest insurance customer, Tricare, while awaiting a final decision after an appeal [1][2]. Company Overview - Zynex, Inc. is a medical technology company founded in 1996, specializing in non-invasive medical devices for pain management, rehabilitation, and patient monitoring [6]. Recent Developments - The company was notified of a temporary suspension of payments from Tricare, which is currently under review [2]. - Zynex's President and CEO, Thomas Sandgaard, indicated that the company presented data to Tricare officials in April to appeal the suspension [2]. Financial Implications - The continuation of the payment suspension may impact Zynex's financial performance until Tricare reaches a final decision [2].